GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea · Delayed Price · Currency is KRW 3,925.00
-170.00 (-4.15%)
At close: May 29, 2026
GeneBioTech Co. ,Ltd Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,589 | 3,789 | 2,865 | 2,591 | 1,523 | -484.4 |
Depreciation & Amortization | 1,384 | 1,387 | 1,368 | 1,338 | 1,286 | 1,244 |
Loss (Gain) From Sale of Assets | -11.22 | 0.15 | -122.26 | -20.69 | 0 | 5.88 |
Asset Writedown & Restructuring Costs | - | - | - | 589.54 | - | - |
Provision & Write-off of Bad Debts | -34.5 | -58.53 | -96.12 | -27.83 | 36.83 | 31.96 |
Other Operating Activities | 645.75 | 490.2 | 797.55 | 1,066 | 284.17 | 155.03 |
Change in Accounts Receivable | -1,080 | 953.98 | -1,662 | 2,464 | -3,955 | -3,602 |
Change in Inventory | 2,469 | 2,966 | -2,239 | 650.04 | -1,806 | -3,390 |
Change in Accounts Payable | 1,486 | 308.34 | -193.85 | -336.71 | -813.24 | 3,088 |
Change in Unearned Revenue | - | - | - | - | - | -1.96 |
Change in Income Taxes | - | - | - | -15.88 | 118.62 | 136.36 |
Change in Other Net Operating Assets | -2,140 | -2,222 | -1,182 | -929.93 | -353.49 | 103.98 |
Operating Cash Flow | 6,308 | 7,614 | -463.87 | 7,369 | -3,679 | -2,713 |
Operating Cash Flow Growth | 11359.98% | - | - | - | - | - |
Capital Expenditures | -3,264 | -3,758 | -1,100 | -530.02 | -1,155 | -3,102 |
Sale of Property, Plant & Equipment | 75.91 | 1 | 224.62 | 23.14 | - | 6.36 |
Sale (Purchase) of Intangibles | -1.74 | -1.74 | -82.71 | -236.9 | -18.91 | -12.28 |
Investment in Securities | -3,773 | -3,733 | 124.03 | -4,608 | 1,685 | 8,397 |
Other Investing Activities | 20.8 | 62.9 | 16.96 | -31.71 | -5.9 | 211.41 |
Investing Cash Flow | -6,826 | -7,312 | -1,030 | -5,326 | 649.96 | 5,745 |
Short-Term Debt Issued | - | 15,645 | 16,673 | 12,398 | 17,015 | 14,232 |
Long-Term Debt Issued | - | 4,240 | 1,830 | 2,200 | 1,375 | 1,000 |
Total Debt Issued | 18,745 | 19,885 | 18,503 | 14,598 | 18,390 | 15,232 |
Short-Term Debt Repaid | - | -18,394 | -13,841 | -14,013 | -15,237 | -10,623 |
Long-Term Debt Repaid | - | -2,484 | -1,686 | -1,298 | -117.76 | -2,984 |
Total Debt Repaid | -18,020 | -20,878 | -15,527 | -15,311 | -15,355 | -13,608 |
Net Debt Issued (Repaid) | 725.13 | -992.94 | 2,976 | -712.61 | 3,035 | 1,625 |
Dividends Paid | - | - | - | - | - | -258.32 |
Other Financing Activities | - | 0 | - | 0 | - | -5,820 |
Financing Cash Flow | 725.13 | -992.94 | 2,976 | -712.61 | 3,035 | -4,453 |
Foreign Exchange Rate Adjustments | 26.85 | -0.95 | 46.92 | -9.59 | -6 | 57.42 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | -0 | - | - |
Net Cash Flow | 234.82 | -692.08 | 1,529 | 1,321 | -0.08 | -1,364 |
Free Cash Flow | 3,044 | 3,856 | -1,564 | 6,838 | -4,834 | -5,816 |
Free Cash Flow Margin | 3.40% | 4.25% | -1.89% | 8.60% | -5.84% | -9.26% |
Free Cash Flow Per Share | 353.93 | 447.87 | -181.81 | 794.19 | -561.41 | -675.39 |
Cash Interest Paid | 479.7 | 557.89 | 621.87 | 177.07 | 181.39 | 36.97 |
Cash Income Tax Paid | 563.5 | 486.34 | 418.01 | 216.78 | -141.85 | 386.84 |
Levered Free Cash Flow | 3,082 | 2,937 | -3,064 | 5,514 | -5,633 | -5,825 |
Unlevered Free Cash Flow | 3,408 | 3,289 | -2,662 | 5,877 | -5,460 | -5,730 |
Change in Working Capital | 735.24 | 2,007 | -5,277 | 1,832 | -6,810 | -3,666 |